Latest News from Arcinova
EBF Workshop Presentation, Lisbon
Stuart McDougall, Bioanalysis Leader, presents 'General Principles of Stability Testing: What Is A Single Source?' at EBF, Lisbon.
EBR Article: Harnessing Hybrids
The October issue of EBR magazine features an article by Bioanalytical Scientist, Michael Blackburn who specialises in Method Development at Arcinova.
Arcinova are now a member of Science Exchange
Arcinova have recently become a member of the Science Exchange.
Arcinova partakes in The Stephen Carey Fund defibrillator training
Coinciding with the recent installation of a defibrillator on site, Arcinova opened its doors to The Stephen Carey Fund in order to learn how to use the life saving equipment.
Arcinova Q2 Newsletter 2017
Our Q2 Newsletter, with important updates including the expansion of our capabilties, new starters and upcoming conferences.
Arcinova Invests in Uniqsis FlowSyn™ Continuous Flow Reactor
In order to facilitate API development, Arcinova have invested in a Uniqsis FlowSyn™ continuous flow reactor.
Integrated Services: Covance and Arcinova strategic relationship
A strategic relationship has been formed between Arcinova and global CRDO Covance. The two companies are now providing integrated services to the global biotech and pharma industry.
Enterprise Hub founding Chair to receive President’s Medal
Director at Arcinova, Ian Shott, is set to receive the President's Medal for his many contributions to the work of the academy over the years, which has ultimately resulted in the creation of the Enterprise Hub.
FW Capital: Arcinova set to grow with £750,000 investment
Alnwick-based independent pharmaceutical contract research and development business Arcinova is set to grow thanks to a £750,000 investment via a loan from the North East Growth Plus Fund managed by FW Capital.